
Mumtaz Balkhi joins TWiP to discuss phase 1 and 1b trials of the schistosomiasis vaccine SchistoShield which demonstrate that it induces functional immune memory responses in US and African populations. Hosts: Vincent Racaniello, Daniel Griffin, and Christina Naula Guest: Mumtaz Y. Balkhi Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Links for this episode Join the MicrobeTV Discord server SchistoShield Phase 1 and 1b results (npj Vaccines) TWiP study – information and survey Become a patron of TWiP Send your questions and comments to twip@microbe.tv Music by Ronald Jenkees
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

TWiP 286: Pinworms keep coming back! How to stop reinfection in your home

TWiP 285: Why Is Cyclospora So Hard to Contain? Parasitologists Explain the 2026 US Outbreak

TWiP 284: It's not the pork

TWiP 283: Warming up to cryptosporidiosis
Free AI-powered recaps of This Week in Parasitism and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.